Physical activity, body size and composition, and risk of ovarian cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
Sankaranarayanan R, Ferlay J (2006) Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 20:207–225
Werness BA, Eltabbakh GH (2001) Familial ovarian cancer and early ovarian cancer: biologic, pathologic, and clinical features. Int J Gynecol Path 20:48–63
Pharoah PD, Ponder BA (2002) The genetics of ovarian cancer. Best Pract Res Clin Obstet Gynaecol 16:449–468
Robles-Diaz L, Goldfrank DJ, Kauff ND, Robson M, Offit K (2004) Hereditary ovarian cancer in Ashkenazi Jews. Fam Cancer 3:259–264
Aarnio M, Sankila R, Pukkala E et al (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81:214–218
Whittemore AS, Harris R, Itnyre J (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 136:1184–1203
Franceschi S, Parazzini F, Negri E et al (1991) Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use. Int J Cancer 49:61–65
Riman T, Persson I, Nilsson S (1998) Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol (Oxf) 49:695–707
Hankinson SE, Colditz GA, Hunter DJ, Spencer TL, Rosner B, Stampfer MJ (1992) A quantitative assessment of oral contraceptive use and risk of ovarian cancer. Obstet Gynecol 80:708–714
Ness RB, Grisso JA, Klapper J et al (2000) Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives. SHARE Study Group. Steroid Hormones and Reproductions. Am J Epidemiol 152:233–241
Weiss NS, Harlow BL (1986) Why does hysterectomy without bilateral oophorectomy influence the subsequent incidence of ovarian cancer? Am J Epidemiol 124:856–858
Irwin KL, Weiss NS, Lee NC, Peterson HB (1991) Tubal sterilization, hysterectomy, and the subsequent occurrence of epithelial ovarian cancer. Am J Epidemiol 134:362–369
Whittemore AS, Wu ML, Paffenbarger RS Jr et al (1989) Epithelial ovarian cancer and the ability to conceive. Cancer Res 49:4047–4052
Cramer DW, Xu H (1995) Epidemiologic evidence for uterine growth factors in the pathogenesis of ovarian cancer. Ann Epidemiol 5:310–314
Hankinson SE, Hunter DJ, Colditz GA et al (1993) Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study. JAMA 270:2813–2818
Miracle-McMahill HL, Calle EE, Kosinski AS et al (1997) Tubal ligation and fatal ovarian cancer in a large prospective cohort study. Am J Epidemiol 145:349–357
Loft A, Lidegaard O, Tabor A (1997) Incidence of ovarian cancer after hysterectomy: a nationwide controlled follow up. Br J Obstet Gynaecol 104:1296–1301
Kreiger N, Sloan M, Cotterchio M, Parsons P (1997) Surgical procedures associated with risk of ovarian cancer. Int J Epidemiol 26:710–715
Rosenblatt KA, Thomas DB (1996) Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer Epidemiol Biomarkers Prev 5:933–935
Russell JB, Mitchell D, Musey PI, Collins DC (1984) The relationship of exercise to anovulatory cycles in female athletes: hormonal and physical characteristics. Obstet Gynecol 63:452–456
Sternfeld B, Jacobs MK, Quesenberry CP Jr, Gold EB, Sowers M (2002) Physical activity and menstrual cycle characteristics in two prospective cohorts. Am J Epidemiol 156:402–409
Kramer MM, Wells CL (1996) Does physical activity reduce risk of estrogen-dependent cancer in women? Med Sci Sports Exerc 28:322–334
Campbell KL, McTiernan A (2007) Exercise and biomarkers for cancer prevention studies. J Nutr 137:161S–169S
Ford ES (2002) Does exercise reduce inflammation?. Physical activity and C-reactive protein among U.S. adults. Epidemiology 13:561–568
Ness RB, Cottreau C (1999) Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 91:1459–1467
De Souza MJ (2003) Menstrual disturbances in athletes: a focus on luteal phase defects. Med Sci Sports Exerc 35:1553–1563
Cannavò S, Curtò L, Trimarchi F (2001) Exercise-related female reproductive dysfunction. J Endocrinol Invest 24:823–832
Shephard RJ, Shek PN (1995) Cancer, immune function, and physical activity. Can J Appl Physiol 20:1–25
Olsen CM, Bain CJ, Jordan SJ et al (2007) Recreational physical activity and epithelial ovarian cancer: a case-control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev 16:2321–2330
Anderson JP, Ross JA, Folsom AR (2004) Anthropometric variables, physical activity, and incidence of ovarian cancer: the Iowa Women’s Health Study. Cancer 100:1515–1521
Bertone ER, Willett WC, Rosner BA et al (2001) Prospective study of recreational physical activity and ovarian cancer. J Natl Cancer Inst 93:942–948
Khaw KT, Barrett-Connor E (1991) Fasting plasma glucose levels and endogenous androgens in non-diabetic postmenopausal women. Clin Sci (Lond) 80:199–203
Key TJ, Allen NE, Verkasalo PK, Banks E (2001) Energy balance and cancer: the role of sex hormones. Proc Nutr Soc 60:81–89
Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579–591
Lukanova A, Lundin E, Toniolo P et al (2002) Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer 101:549–554
Olsen CM, Green AC, Whiteman DC, Sadeghi S, Kolahdooz F, Webb PM (2007) Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer 43:690–709
Giles GG (1990) The Melbourne study of diet and cancer. Proc Nutr Soc Aust 15:61–68
Ireland P, Jolley D, Giles G et al (1994) Development of the Melbourne FFQ: a food frequency questionnaire for use in an Australian prospective study involving an ethnically diverse cohort. Asia Pac J Clin Nutr 3:19–31
Lewis J, Milligan G, Hunt A (1995) NUTTAB 95 nutrient data table for use in Australia. Australian Government Publishing Service, Canberra
Korn EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145:72–80
Kirkwood BR, Sterne JAC (2003) Regression analysis of survival data. In: essential medical statistics, 2nd edn. Blackwell Science, Massachusetts, pp 287–294
Roubenoff R, Baumgartner RN, Harris TB et al (1997) Application of bioelectrical impedance analysis to elderly populations. J Gerontol A Biol Sci Med Sci 52:M129–M136
WHO Expert Committee. Physical Status (1995) The use and interpretation of anthropometry. WHO, Geneva
Risk Factor Prevalence Management Committee (1990) Risk factor prevalence study: survey number 3, 1989. National Heart Foundation of Australia and Australian Institute of Health, Canberra
Booth ML, Owen N, Bauman AE, Gore CJ (1996) Retest reliability of recall measures of leisure-time physical activity in Australian adults. Int J Epidemiol 25:153–159
Booth ML, Owen N, Bauman A, Gore CJ (1996) Relationship between a 14-day recall measure of leisure-time physical activity and a submaximal test of physical work capacity in a population sample of Australian adults. Res Q Exerc Sport 67:221–227
Pan SY, Ugnat A, Mao Y et al (2005) Physical activity and the risk of ovarian cancer: a case-control study in Canada. Int J Cancer 117:300–307
Riman T, Dickman PW, Nilsson S, Nordlinder H, Magnusson CM, Persson IR (2004) Some life-style factors and the risk of invasive epithelial ovarian cancer in Swedish women. Eur J Epidemiol 19:1011–1019
Tavani A, Gallus S, La Vecchia C et al (2001) Physical activity and risk of ovarian cancer: an Italian case-control study. Int J Cancer 91:407–411
Cottreau CM, Ness RB, Kriska AM (2000) Physical activity and reduced risk of ovarian cancer. Obstet Gynecol 96:609–614
Weiderpass E, Margolis KL, Sandin S et al (2006) Prospective study of physical activity in different periods of life and the risk of ovarian cancer. Int J Cancer 118:3153–3160
Bertone ER, Newcomb PA, Willett WC, Stampfer MJ, Egan KM (2002) Recreational physical activity and ovarian cancer in a population-based case-control study. Int J Cancer 99:431–436
Patel AV, Rodriguez C, Pavluck AL, Thun MJ, Calle EE (2006) Recreational physical activity and sedentary behaviour in relation to ovarian cancer risk in a large cohort of US women. Am J Epidemiol 163:709–716
Lahmann PH, Friedenreich C, Schulz M et al (2009) Physical activity and ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 18:351–354
Leitzmann MF, Koebnick C, Moore SC et al (2009) Prospective study of physical activity and the risk of ovarian cancer. Cancer Causes Control 20:765–773
Bull FC, Bauman AE, Bellew B, Brown WJ (2004) Getting Australia active II: an update of evidence on physical activity. National Public Health Partnership, Melbourne
Lee IM (2003) Physical activity and cancer prevention—data from epidemiologic studies. Med Sci Sports Exerc 35:1823–1827
Slattery ML, Edwards SL, Ma KN, Friedman GD, Potter JD (1997) Physical activity and colon cancer: a public health perspective. Ann Epidemiol 7:137–145
International Agency for Research in Cancer Working Group on the Evaluation of Cancer-preventive Strategies (IARC Working Group) (2002) Handbooks of cancer prevention. Volume 6: weight control and physical activity. IARC Press, Lyon
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, Million Women Study Collaboration (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335:1134
Leitzmann MF, Koebnick C, Danforth KN et al (2009) Body mass index and risk of ovarian cancer. Cancer 115:812–822
Lacey JV Jr, Leitzmann M, Brinton LA et al (2006) Weight, height, and body mass index and risk for ovarian cancer in a cohort study. Ann Epidemiol 16:869–876
Lahmann PH, Cust AE, Friedenreich CM et al (2010) Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 126:2404–2415
Dal Maso L, Franceschi S, Negri E et al (2002) Body size indices at different ages and epithelial ovarian cancer risk. Eur J Cancer 38:1769–1774
Hoyo C, Berchuck A, Halabi S et al (2005) Anthropometric measurements and epithelial ovarian cancer risk in African-American and White women. Cancer Causes Control 16:955–963
Engeland A, Tretli S, Bjørge T (2003) Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst 95:1244–1248
Rapp K, Schroeder J, Klenk J et al (2005) Obesity and incidence of cancer: a large cohort study of over 145, 000 adults in Austria. Br J Cancer 93:1062–1067
Lukanova A, Björ O, Kaaks R et al (2006) Body mass index and cancer: results from the Northern Sweden Health and Disease Cohort. Int J Cancer 118:458–466
Schouten LJ, Goldbohm RA, van den Brandt PA (2003) Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol 157:424–433
Jonsson F, Wolk A, Pedersen N et al (2003) Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer 106:594–599
Baer HJ, Hankinson SE, Tworoger SS (2008) Body size in early life and risk of epithelial ovarian cancer: results from the Nurses’ Health Studies. Br J Cancer 99:1916–1922
Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM (2001) Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 23:313–342
Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS (2009) Recreational physical activity and risk of epithelial ovarian cancer. Cancer Causes Control 21:485–491
Olsen CM, Nagle CM, Whiteman DC, Purdie DM, Green AC, Webb PM (2008) Body size and risk of epithelial ovarian and related cancers: a population-based case-control study. Int J Cancer 123:450–456
Greer JB, Modugno F, Ness RB, Allen GO (2006) Anthropometry and the risk of epithelial ovarian cancer. Cancer 106:2247–2257
Mills PK, Riordan DG, Cress RD (2004) Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California. Gynecol Oncol 95:215–225
Kuper H, Cramer DW, Titus-Ernstoff L (2002) Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status? Cancer Causes Control 13:455–463
Purdie DM, Bain CJ, Webb PM, Whiteman DC, Pirozzo S, Green AC (2001) Body size and ovarian cancer: case-control study and systematic review (Australia). Cancer Causes Control 12:855–863
Farrow DC, Weiss NS, Lyon JL, Daling JR (1989) Association of obesity and ovarian cancer in a case-control study. Am J Epidemiol 129:1300–1304
Soegaard M, Jensen A, Hogdall E et al (2007) Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study. Cancer Epidemiol Biomarkers Prev 16:1160–1166
Fairfield KM, Willett WC, Rosner BA, Manson JE, Speizer FE, Hankinson SE (2002) Obesity, weight gain, and ovarian cancer. Obstet Gynecol 100:288–296
Kurian AW, Balise RR, McGuire V, Whittemore AS (2005) Histologic types of epithelial ovarian cancer: have they different risk factors? Gynecol Oncol 96:520–530
Schouten LJ, Rivera C, Hunter DJ et al (2008) Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev 17:902–912
Godwin AK, Perez RP, Johnson SW, Hamaguchi K, Hamilton TC (1992) Growth regulation of ovarian cancer. Hematol Oncol Clin North Am 6:829–841
Cramer DW, Welch WR (1983) Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 71:717–721
Coyle YM (2008) Physical activity as a negative modulator of estrogen-induced breast cancer. Cancer Causes Control 19:1021–1029
Helzlsouer KJ, Alberg AJ, Gordon GB et al (1995) Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 274:1926–1930
Yen SS (1994) Endocrinology of pregnancy. In: Creasy RK, Rensik R (eds) Maternal-fetal medicine: principles and practice. Saunders, Philadelphia, pp 382–412
King RJ (1991) Biology of female sex hormone action in relation to contraceptive agents and neoplasia. Contraception 43:527–542
Gabra H, Taylor L, Cohen BB et al (1995) Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours. Br J Cancer 72:367–375
Davis M, Hitchcock A, Foulkes WD, Campbell IG (1996) Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer. Cancer Res 56:741–744
Gabra H, Watson JE, Taylor KJ et al (1996) Definition and refinement of a region of loss of heterozygosity at 11q23.3–q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res 56:950–954
Ellison PT, Lager C (1986) Moderate recreational running is associated with lowered salivary progesterone profiles in women. Am J Obstet Gynecol 154:1000–1003
Mathur RS, Neff MR, Landgrebe SC et al (1986) Time-related changes in the plasma concentrations of prolactin, gonadotropins, sex hormone-binding globulin, and certain steroid hormones in female runners after a long-distance race. Fertil Steril 46:1067–1070
Shangold MM, Gatz ML, Thysen B (1981) Acute effects of exercise on plasma concentrations of prolactin and testosterone in recreational women runners. Fertil Steril 35:699–702
Dunn SE, Kari FW, French J et al (1997) Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 57:4667–4672
Ng ST, Zhou J, Adesanya OO, Wang J, LeRoith D, Bondy CA (1997) Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat Med 3:1141–1144
Cianfarani S, Tedeschi B, Germani D et al (1998) In vitro effects of growth hormone (GH) and insulin-like growth factor I and II (IGF-I and -II) on chromosome fragility and p53 protein expression in human lymphocytes. Eur J Clin Invest 28:41–47
Singh KB, Mahajan DK, Wortsman J (1994) Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome. J Reprod Med 39:805–808